This inventor holds 229 USPTO granted patents and 28 published patent applications, plus 4 CIPO patents and 38 EPO patents, primarily in Drug-Coated Balloon Catheters (CPC class A61L29-16). Top assignees: Scimed Life Systems, Inc., Lutonix Inc., Boston Scientific Scimed, Inc.. Active years: 1994-2026. Education: Nanjing University (China); Changchun Institute of Applied Chemistry, Academia Sinica (China); University of Wisconsin-Madison (USA).
Graduated from:
- Nanjing University (China)
- Changchun Institute of Applied Chemistry, Academia Sinica (China)
- University of Wisconsin-Madison (USA)
Inventors with similar research interests:
Location History:
- Minneapolis, MN (US) (1996 - 1998)
- Saint Paul, MN (US) (1994 - 2010)
- Maple Grove, MN (US) (1995 - 2010)
- Long Lake, MN (US) (2001 - 2019)
- Plymouth, MN (US) (2020)
- Medina, MN (US) (2007 - 2024)
- Henderson, NV (US) (2019 - 2024)
Company Filing History:
87 out of 1,831 
45 out of 46 
34 out of 6,572 
Years Active: 1994-2026
Areas of Expertise:
Title: Innovator Spotlight: Lixiao Wang Revolutionizing Medical Treatment in Henderson, NV
Introduction: Meet Lixiao Wang, a prolific inventor based in Henderson, Nevada, with an impressive 208 patents to his name. Wang's groundbreaking work focuses on developing innovative solutions for treating various nonvascular strictures, including those found in the urethra, prostate, esophagus, sinuses, and biliary tract.
Latest Patents: Wang's recent patents showcase his expertise in creating drug-coated balloon catheters for nonvascular strictures. These catheters deliver anti-inflammatory and anti-proliferative drugs, such as rapamycin and paclitaxel, to effectively treat conditions like benign prostatic hyperplasia (BPH), prostate cancer, asthma, and chronic obstructive pulmonary disease (COPD). His inventions offer a minimally invasive and targeted approach to stricture treatment, improving patient outcomes.
Career Highlights: Wang has made significant contributions to the medical device industry through his work at renowned companies like Scimed Life Systems, Inc., and Lutonix Inc. His invaluable experience and dedication to innovation have led to the development of cutting-edge medical technologies that are transforming the field of interventional medicine.
Collaborations: Throughout his career, Wang has collaborated with notable experts in the industry, including his coworkers John Jianhua Chen and Jianhua Chen. Together, they have worked tirelessly to bring Wang's visionary ideas to life and advance the standard of care for patients suffering from nonvascular strictures.
Conclusion: Lixiao Wang's pioneering spirit and relentless drive for innovation have established him as a trailblazer in the medical device industry. His revolutionary inventions, such as drug-coated balloon catheters for body lumen strictures, have the potential to revolutionize medical treatment practices and significantly improve patient quality of life. Wang's impressive patent portfolio and collaborative efforts underscore his commitment to pushing the boundaries of medical innovation, making him a true visionary in the field.